Polymyalgia Rheumatica

Polymyalgia Rheumatica (PMR) is an inflammatory disorder characterized by widespread musculoskeletal pain and stiffness, typically affecting the shoulders, neck, hips, and proximal limb girdles. It predominantly occurs in individuals aged 50 and older, with a higher incidence in women. Morning stiffness is a hallmark symptom, often lasting for more than 45 minutes, and it can significantly impair daily activities. Elevated inflammatory markers, such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), are commonly observed in PMR. The exact cause of PMR remains unclear, but it is believed to involve autoimmune mechanisms. In some cases, PMR may be associated with giant cell arteritis, a condition affecting medium and large arteries. Glucocorticoids, specifically prednisone, are the mainstay of treatment for PMR, providing rapid relief of symptoms. However, long-term use of steroids poses potential side effects, necessitating careful management and monitoring. PMR has a favorable prognosis, and symptoms often subside with appropriate treatment, but relapses can occur. Regular medical follow-up is crucial to adjust medication dosages and monitor for potential complications, emphasizing the importance of a multidisciplinary approach in managing this rheumatologic condition.